Search research articles
Contact Us
Filters
Showing results (21-30 of 81) with videos related to
Page
of 9
Sort By:
Clinical and Experimental Rheumatology
|
October 18, 2016
Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
Benjamin A Fisher, Philippe Donatien, Andrew Filer, et al.
Arthritis and Rheumatism
|
September 30, 2008
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase
Karin Lundberg, Andrew Kinloch, Benjamin A Fisher, et al.
Rheumatology (Oxford, England)
|
June 24, 2026
Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls
Matilde Bandeira, Aliaksandra Baranskaya, Valentina Pucino, et al.
Annals of the Rheumatic Diseases
|
March 19, 2013
Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease
Benjamin A Fisher, So-Young Bang, Muslima Chowdhury, et al.
Annals of the Rheumatic Diseases
|
March 4, 2011
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis
Benjamin A Fisher, Darren Plant, Monica Brode, et al.
The Journal of Rheumatology
|
February 17, 2017
Plasma Levels of Eicosapentaenoic Acid Are Associated with Anti-TNF Responsiveness in Rheumatoid Arthritis and Inhibit the Etanercept-driven Rise in Th17 Cell Differentiation <i>in Vitro</i>
Louisa Jeffery, Helena L Fisk, Philip C Calder, et al.
Arthritis and Rheumatism
|
March 6, 2013
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis
Sabrina R Kapoor, Andrew Filer, Martin A Fitzpatrick, et al.
Rheumatology and Therapy
|
October 10, 2024
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL)
Jessica Marvel, Elizabeth Gargon, Chloe Howse, et al.
RMD Open
|
May 19, 2022
Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature
Valentina Pucino, Jason D Turner, Saba Nayar, et al.
Clinical and Experimental Rheumatology
|
October 23, 2020
Mediterranean diet and risk of Sjögren's syndrome
Aleksander Machowicz, Isaac Hall, Paola de Pablo, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 81) with videos related to
Sort By:
Page
of 9
Clinical and Experimental Rheumatology
|
October 18, 2016
Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
Benjamin A Fisher, Philippe Donatien, Andrew Filer, et al.
Arthritis and Rheumatism
|
September 30, 2008
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase
Karin Lundberg, Andrew Kinloch, Benjamin A Fisher, et al.
Rheumatology (Oxford, England)
|
June 24, 2026
Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls
Matilde Bandeira, Aliaksandra Baranskaya, Valentina Pucino, et al.
Annals of the Rheumatic Diseases
|
March 19, 2013
Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease
Benjamin A Fisher, So-Young Bang, Muslima Chowdhury, et al.
Annals of the Rheumatic Diseases
|
March 4, 2011
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis
Benjamin A Fisher, Darren Plant, Monica Brode, et al.
The Journal of Rheumatology
|
February 17, 2017
Plasma Levels of Eicosapentaenoic Acid Are Associated with Anti-TNF Responsiveness in Rheumatoid Arthritis and Inhibit the Etanercept-driven Rise in Th17 Cell Differentiation <i>in Vitro</i>
Louisa Jeffery, Helena L Fisk, Philip C Calder, et al.
Arthritis and Rheumatism
|
March 6, 2013
Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis
Sabrina R Kapoor, Andrew Filer, Martin A Fitzpatrick, et al.
Rheumatology and Therapy
|
October 10, 2024
The Development and Content Validation of the Sjögren's Related Quality of Life Instrument (SRQoL)
Jessica Marvel, Elizabeth Gargon, Chloe Howse, et al.
RMD Open
|
May 19, 2022
Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature
Valentina Pucino, Jason D Turner, Saba Nayar, et al.
Clinical and Experimental Rheumatology
|
October 23, 2020
Mediterranean diet and risk of Sjögren's syndrome
Aleksander Machowicz, Isaac Hall, Paola de Pablo, et al.
Page
of 9